tradingkey.logo

ICAD Inc

ICAD
Ver gráfico detallado

3.870USD

0.000
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
105.19MCap. mercado
PérdidaP/E TTM
Intraday
1m
30m
1h
D
W
M
D

Hoy

0.00%

5 Días

+Infinity%

1 Mes

+Infinity%

6 Meses

+56.68%

Año hasta la fecha

+111.48%

Un año

+148.08%

Ver gráfico detallado

Puntuación de acciones TradingKey

Sin datos de puntuación

Noticias

Próximamente más noticias, permanezca atento...

Indicadores financieros

BPA

Sin datos

Ingresos totales

Sin datos

Compañía

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.
Símbolo de cotizaciónICAD
CompañíaICAD Inc
Director ejecutivoMs. Dana R. Brown
Sitio Webhttps://www.icadmed.com/
KeyAI